

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine metabolic process (GO:0006558) | 4.71229578 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.71229578 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 4.68475179 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.68475179 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 4.50866182 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.48061975 |
| 7 | sulfur amino acid catabolic process (GO:0000098) | 4.24821388 |
| 8 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.90659407 |
| 9 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.88482183 |
| 10 | protein carboxylation (GO:0018214) | 3.82263342 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.82263342 |
| 12 | low-density lipoprotein particle clearance (GO:0034383) | 3.70165901 |
| 13 | paraxial mesoderm development (GO:0048339) | 3.67548450 |
| 14 | cysteine metabolic process (GO:0006534) | 3.61652115 |
| 15 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.61242593 |
| 16 | plasma lipoprotein particle clearance (GO:0034381) | 3.59937302 |
| 17 | aromatic amino acid family catabolic process (GO:0009074) | 3.58956762 |
| 18 | negative regulation of fibrinolysis (GO:0051918) | 3.56304873 |
| 19 | high-density lipoprotein particle remodeling (GO:0034375) | 3.54823958 |
| 20 | acylglycerol catabolic process (GO:0046464) | 3.54123661 |
| 21 | neutral lipid catabolic process (GO:0046461) | 3.54123661 |
| 22 | regulation of triglyceride catabolic process (GO:0010896) | 3.49232248 |
| 23 | cellular modified amino acid catabolic process (GO:0042219) | 3.49059353 |
| 24 | regulation of cholesterol homeostasis (GO:2000188) | 3.48596213 |
| 25 | triglyceride catabolic process (GO:0019433) | 3.47790603 |
| 26 | positive regulation of lipid catabolic process (GO:0050996) | 3.47121268 |
| 27 | triglyceride homeostasis (GO:0070328) | 3.45372398 |
| 28 | acylglycerol homeostasis (GO:0055090) | 3.45372398 |
| 29 | lysine metabolic process (GO:0006553) | 3.41828486 |
| 30 | lysine catabolic process (GO:0006554) | 3.41828486 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 3.40086259 |
| 32 | glutamate metabolic process (GO:0006536) | 3.34088815 |
| 33 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.33865043 |
| 34 | coenzyme catabolic process (GO:0009109) | 3.28904698 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.24917600 |
| 36 | 4-hydroxyproline metabolic process (GO:0019471) | 3.24825466 |
| 37 | urea cycle (GO:0000050) | 3.22620967 |
| 38 | urea metabolic process (GO:0019627) | 3.22620967 |
| 39 | epoxygenase P450 pathway (GO:0019373) | 3.21900656 |
| 40 | regulation of fibrinolysis (GO:0051917) | 3.16325251 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.12701578 |
| 42 | short-chain fatty acid metabolic process (GO:0046459) | 3.11614191 |
| 43 | collagen fibril organization (GO:0030199) | 3.11481614 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.10604314 |
| 45 | desmosome organization (GO:0002934) | 3.09556416 |
| 46 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.08852162 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.08537632 |
| 48 | phospholipid efflux (GO:0033700) | 3.08275204 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.06929812 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.06929812 |
| 51 | plasma lipoprotein particle remodeling (GO:0034369) | 3.06929812 |
| 52 | serine family amino acid catabolic process (GO:0009071) | 3.05121854 |
| 53 | kidney mesenchyme development (GO:0072074) | 3.04724349 |
| 54 | chondrocyte proliferation (GO:0035988) | 3.04703676 |
| 55 | kynurenine metabolic process (GO:0070189) | 3.03602476 |
| 56 | valine metabolic process (GO:0006573) | 3.03493887 |
| 57 | negative regulation of hormone metabolic process (GO:0032351) | 3.02424205 |
| 58 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.01242955 |
| 59 | homocysteine metabolic process (GO:0050667) | 3.01208362 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.00664310 |
| 61 | tyrosine metabolic process (GO:0006570) | 3.00379055 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 2.99603180 |
| 63 | negative regulation of lipase activity (GO:0060192) | 2.98014439 |
| 64 | cellular ketone body metabolic process (GO:0046950) | 2.97977177 |
| 65 | metanephric mesenchyme development (GO:0072075) | 2.97527428 |
| 66 | biotin metabolic process (GO:0006768) | 2.96746798 |
| 67 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.96735736 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 2.94287307 |
| 69 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.92886051 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 2.92318231 |
| 71 | negative regulation of sterol transport (GO:0032372) | 2.92318231 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 2.91219538 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 2.90466650 |
| 74 | bile acid metabolic process (GO:0008206) | 2.90162487 |
| 75 | skin morphogenesis (GO:0043589) | 2.89791011 |
| 76 | fatty acid beta-oxidation (GO:0006635) | 2.88081034 |
| 77 | fatty acid oxidation (GO:0019395) | 2.87569765 |
| 78 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.87528069 |
| 79 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.87476146 |
| 80 | alpha-amino acid catabolic process (GO:1901606) | 2.86816237 |
| 81 | intestinal absorption (GO:0050892) | 2.86794678 |
| 82 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.85898458 |
| 83 | regulation of protein activation cascade (GO:2000257) | 2.83853584 |
| 84 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.83351418 |
| 85 | lipid oxidation (GO:0034440) | 2.80208198 |
| 86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.79877468 |
| 87 | cellular response to vitamin (GO:0071295) | 2.78804371 |
| 88 | thioester biosynthetic process (GO:0035384) | 2.78248832 |
| 89 | acyl-CoA biosynthetic process (GO:0071616) | 2.78248832 |
| 90 | triglyceride metabolic process (GO:0006641) | 2.77547576 |
| 91 | endodermal cell differentiation (GO:0035987) | 2.76447119 |
| 92 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.75796655 |
| 93 | protein localization to endosome (GO:0036010) | 2.75450928 |
| 94 | aspartate family amino acid catabolic process (GO:0009068) | 2.73978480 |
| 95 | fatty acid catabolic process (GO:0009062) | 2.73926286 |
| 96 | hormone catabolic process (GO:0042447) | 2.70039524 |
| 97 | regulation of sequestering of triglyceride (GO:0010889) | 2.69546726 |
| 98 | positive regulation of glycolytic process (GO:0045821) | 2.69192047 |
| 99 | monocarboxylic acid catabolic process (GO:0072329) | 2.68457314 |
| 100 | aromatic amino acid family metabolic process (GO:0009072) | 2.67251317 |
| 101 | regulation of complement activation (GO:0030449) | 2.67042783 |
| 102 | protein heterotrimerization (GO:0070208) | 2.66748217 |
| 103 | acylglycerol metabolic process (GO:0006639) | 2.66433096 |
| 104 | regulation of triglyceride metabolic process (GO:0090207) | 2.65509362 |
| 105 | cholesterol efflux (GO:0033344) | 2.65327241 |
| 106 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.64888406 |
| 107 | regulation of lipid catabolic process (GO:0050994) | 2.64476888 |
| 108 | neutral lipid metabolic process (GO:0006638) | 2.63871714 |
| 109 | drug catabolic process (GO:0042737) | 2.63548790 |
| 110 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.63399195 |
| 111 | linoleic acid metabolic process (GO:0043651) | 2.63395605 |
| 112 | ethanol oxidation (GO:0006069) | 2.63114449 |
| 113 | fatty acid transmembrane transport (GO:1902001) | 2.62116646 |
| 114 | fatty acid homeostasis (GO:0055089) | 2.62040564 |
| 115 | regulation of fatty acid oxidation (GO:0046320) | 2.60448787 |
| 116 | regulation of plasminogen activation (GO:0010755) | 2.59635947 |
| 117 | glycerolipid catabolic process (GO:0046503) | 2.59179094 |
| 118 | 2-oxoglutarate metabolic process (GO:0006103) | 2.58501953 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 2.58491764 |
| 120 | organic acid catabolic process (GO:0016054) | 2.58491764 |
| 121 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.57090029 |
| 122 | COPII vesicle coating (GO:0048208) | 2.56495421 |
| 123 | gap junction assembly (GO:0016264) | 2.54489352 |
| 124 | adhesion of symbiont to host cell (GO:0044650) | 2.53699002 |
| 125 | virion attachment to host cell (GO:0019062) | 2.53699002 |
| 126 | non-canonical Wnt signaling pathway (GO:0035567) | 2.52520484 |
| 127 | protein retention in ER lumen (GO:0006621) | 2.51411271 |
| 128 | negative regulation of gluconeogenesis (GO:0045721) | 2.50740841 |
| 129 | transcytosis (GO:0045056) | 2.48391827 |
| 130 | adhesion of symbiont to host (GO:0044406) | 2.47890225 |
| 131 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.44993125 |
| 132 | peptidyl-proline hydroxylation (GO:0019511) | 2.43815747 |
| 133 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.40945056 |
| 134 | negative regulation of glycogen metabolic process (GO:0070874) | 2.39534155 |
| 135 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.38313141 |
| 136 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.37802693 |
| 137 | endothelial cell morphogenesis (GO:0001886) | 2.35331401 |
| 138 | negative regulation of fatty acid transport (GO:2000192) | 2.34196925 |
| 139 | smooth muscle tissue development (GO:0048745) | 2.33270983 |
| 140 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.32697305 |
| 141 | anterior/posterior axis specification, embryo (GO:0008595) | 2.32483297 |
| 142 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.31172425 |
| 143 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.30927999 |
| 144 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.30881322 |
| 145 | regulation of extracellular matrix disassembly (GO:0010715) | 2.28626521 |
| 146 | bone trabecula formation (GO:0060346) | 2.27506856 |
| 147 | convergent extension (GO:0060026) | 2.27102234 |
| 148 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.26164850 |
| 149 | negative regulation of heart growth (GO:0061117) | 2.26164850 |
| 150 | type B pancreatic cell proliferation (GO:0044342) | 2.24808509 |
| 151 | cellular response to vitamin D (GO:0071305) | 2.22847464 |
| 152 | cochlea morphogenesis (GO:0090103) | 2.21808986 |
| 153 | ethanol metabolic process (GO:0006067) | 2.21463654 |
| 154 | regulation of establishment of planar polarity (GO:0090175) | 2.21369894 |
| 155 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.19116722 |
| 156 | notochord development (GO:0030903) | 2.18108017 |
| 157 | primary alcohol metabolic process (GO:0034308) | 2.18005296 |
| 158 | regulation of lipoprotein metabolic process (GO:0050746) | 2.17921763 |
| 159 | protein hydroxylation (GO:0018126) | 2.16463738 |
| 160 | epithelial cell-cell adhesion (GO:0090136) | 2.16112710 |
| 161 | polarized epithelial cell differentiation (GO:0030859) | 2.15361271 |
| 162 | angiotensin maturation (GO:0002003) | 2.13426972 |
| 163 | negative regulation of cardiac muscle tissue development (GO:0055026) | 2.13146166 |
| 164 | basement membrane organization (GO:0071711) | 2.12022844 |
| 165 | inner ear receptor cell development (GO:0060119) | 2.09527394 |
| 166 | establishment of tissue polarity (GO:0007164) | 2.09159103 |
| 167 | establishment of planar polarity (GO:0001736) | 2.09159103 |
| 168 | retinol metabolic process (GO:0042572) | 2.08902690 |
| 169 | cell differentiation involved in metanephros development (GO:0072202) | 2.08438026 |
| 170 | intestinal cholesterol absorption (GO:0030299) | 2.08328765 |
| 171 | cell adhesion mediated by integrin (GO:0033627) | 2.06882634 |
| 172 | cellular response to nutrient (GO:0031670) | 2.06265138 |
| 173 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.05767363 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.05763764 |
| 175 | outer ear morphogenesis (GO:0042473) | 2.04528852 |
| 176 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.04264039 |
| 177 | ER overload response (GO:0006983) | 2.04181490 |
| 178 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.03722015 |
| 179 | response to hepatocyte growth factor (GO:0035728) | 2.03722015 |
| 180 | middle ear morphogenesis (GO:0042474) | 2.01601029 |
| 181 | positive regulation of osteoblast proliferation (GO:0033690) | 2.01394537 |
| 182 | trabecula formation (GO:0060343) | 2.00291122 |
| 183 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 1.98811270 |
| 184 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 1.98811270 |
| 185 | very-low-density lipoprotein particle assembly (GO:0034379) | 1.98715249 |
| 186 | branching involved in salivary gland morphogenesis (GO:0060445) | 1.97970068 |
| 187 | cellular glucuronidation (GO:0052695) | 1.96991291 |
| 188 | NADH metabolic process (GO:0006734) | 1.96702825 |
| 189 | chondrocyte development (GO:0002063) | 1.96167969 |
| 190 | endocardial cushion development (GO:0003197) | 1.95881309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.04890127 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.47958812 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.52120584 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.96348048 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.87893175 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.83889651 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.77184712 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.66282777 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.58712986 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.49326519 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.46539202 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25378000 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.03041402 |
| 14 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.81602164 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75349349 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74216984 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71226486 |
| 18 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.68295421 |
| 19 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.66125556 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.58269466 |
| 21 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53858906 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.51476976 |
| 23 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.50827906 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47886716 |
| 25 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.41673570 |
| 26 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.41381592 |
| 27 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.39395114 |
| 28 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.37184827 |
| 29 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.35558931 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34992388 |
| 31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34727313 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.33707516 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33298033 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.32686478 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31658983 |
| 36 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.29814419 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28801800 |
| 38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28478940 |
| 39 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.28208536 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26613956 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.23997865 |
| 42 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23844787 |
| 43 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.23427209 |
| 44 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22600176 |
| 45 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.20142057 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.19596781 |
| 47 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16210115 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.15310553 |
| 49 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15182977 |
| 50 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.14571390 |
| 51 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.13967380 |
| 52 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13817135 |
| 53 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.13052871 |
| 54 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.13052871 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12808190 |
| 56 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12286170 |
| 57 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11403283 |
| 58 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.10822727 |
| 59 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.09121078 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08746810 |
| 61 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08573262 |
| 62 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.08149085 |
| 63 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.06641235 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06310168 |
| 65 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.05933798 |
| 66 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05293403 |
| 67 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.04901415 |
| 68 | ATF3_27146783_Chip-Seq_COLON_Human | 1.04893328 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04323433 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.03785069 |
| 71 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.03575329 |
| 72 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03489846 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.03125348 |
| 74 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02608528 |
| 75 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.02223968 |
| 76 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02101004 |
| 77 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.01825222 |
| 78 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00276374 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99572746 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.99501064 |
| 81 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97554271 |
| 82 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.97488587 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.97446926 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.97446926 |
| 85 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97430080 |
| 86 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96805640 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96428846 |
| 88 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95693799 |
| 89 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.95380987 |
| 90 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.95211516 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.94869082 |
| 92 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93952670 |
| 93 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.93916972 |
| 94 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.93916972 |
| 95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93845191 |
| 96 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93757116 |
| 97 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93611218 |
| 98 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.93106074 |
| 99 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92819035 |
| 100 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92406808 |
| 101 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.92205408 |
| 102 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.92143336 |
| 103 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91176417 |
| 104 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.91126250 |
| 105 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.90766087 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.90633522 |
| 107 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.90415107 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90174172 |
| 109 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89356087 |
| 110 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.88565853 |
| 111 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88019647 |
| 112 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.87657350 |
| 113 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.87332917 |
| 114 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.87249097 |
| 115 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86510411 |
| 116 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.85691183 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.85205750 |
| 118 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.85165283 |
| 119 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.85105994 |
| 120 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.85091833 |
| 121 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84869388 |
| 122 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84312944 |
| 123 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.84249563 |
| 124 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.83985189 |
| 125 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82227956 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81524552 |
| 127 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81351005 |
| 128 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81253945 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.80358822 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80311716 |
| 131 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80109284 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.79055324 |
| 133 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79013746 |
| 134 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.78541087 |
| 135 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78450879 |
| 136 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78381147 |
| 137 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77264498 |
| 138 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.76567167 |
| 139 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.75810252 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.75592919 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74999919 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.58535639 |
| 2 | MP0005360_urolithiasis | 4.91183335 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.74165375 |
| 4 | MP0005365_abnormal_bile_salt | 3.62615089 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.53836062 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.96284784 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.88518703 |
| 8 | MP0005503_abnormal_tendon_morphology | 2.81441444 |
| 9 | MP0003941_abnormal_skin_development | 2.70483130 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.67438224 |
| 11 | MP0003252_abnormal_bile_duct | 2.57309034 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.48134672 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.46534368 |
| 14 | MP0002796_impaired_skin_barrier | 2.38355609 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.35671954 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.29362896 |
| 17 | MP0005275_abnormal_skin_tensile | 2.24873065 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.21800677 |
| 19 | MP0003279_aneurysm | 2.07996195 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.02189856 |
| 21 | MP0004130_abnormal_muscle_cell | 1.92699453 |
| 22 | MP0002254_reproductive_system_inflammat | 1.92691634 |
| 23 | MP0009840_abnormal_foam_cell | 1.91006993 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.80214407 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.79130424 |
| 26 | MP0005670_abnormal_white_adipose | 1.77964735 |
| 27 | MP0005332_abnormal_amino_acid | 1.75948734 |
| 28 | MP0005083_abnormal_biliary_tract | 1.74730878 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.72577093 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.68363334 |
| 31 | MP0004272_abnormal_basement_membrane | 1.61147033 |
| 32 | MP0010030_abnormal_orbit_morphology | 1.61046026 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.60363465 |
| 34 | MP0005375_adipose_tissue_phenotype | 1.59328590 |
| 35 | MP0003195_calcinosis | 1.58056608 |
| 36 | MP0001958_emphysema | 1.56198698 |
| 37 | MP0002877_abnormal_melanocyte_morpholog | 1.53809869 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.45780483 |
| 39 | MP0003329_amyloid_beta_deposits | 1.44251042 |
| 40 | MP0005623_abnormal_meninges_morphology | 1.44112295 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.43026413 |
| 42 | MP0000609_abnormal_liver_physiology | 1.42704869 |
| 43 | MP0004858_abnormal_nervous_system | 1.41320068 |
| 44 | MP0002971_abnormal_brown_adipose | 1.39838678 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.39003265 |
| 46 | MP0003942_abnormal_urinary_system | 1.33691326 |
| 47 | MP0000462_abnormal_digestive_system | 1.29932065 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.29918298 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.29757378 |
| 50 | MP0001188_hyperpigmentation | 1.28708879 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.26398243 |
| 52 | MP0000534_abnormal_ureter_morphology | 1.23033708 |
| 53 | MP0002108_abnormal_muscle_morphology | 1.21562251 |
| 54 | MP0005409_darkened_coat_color | 1.17756780 |
| 55 | MP0002060_abnormal_skin_morphology | 1.15492996 |
| 56 | MP0005501_abnormal_skin_physiology | 1.14099066 |
| 57 | MP0005319_abnormal_enzyme/_coenzyme | 1.13698787 |
| 58 | MP0003283_abnormal_digestive_organ | 1.11970891 |
| 59 | MP0009250_abnormal_appendicular_skeleto | 1.08655384 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.08596198 |
| 61 | MP0000566_synostosis | 1.07506315 |
| 62 | MP0002078_abnormal_glucose_homeostasis | 1.07016679 |
| 63 | MP0004043_abnormal_pH_regulation | 1.05591405 |
| 64 | MP0000428_abnormal_craniofacial_morphol | 1.04964377 |
| 65 | MP0005334_abnormal_fat_pad | 1.03176612 |
| 66 | MP0003755_abnormal_palate_morphology | 1.01782870 |
| 67 | MP0005023_abnormal_wound_healing | 1.01733155 |
| 68 | MP0003123_paternal_imprinting | 1.01447463 |
| 69 | MP0001542_abnormal_bone_strength | 1.00871939 |
| 70 | MP0010368_abnormal_lymphatic_system | 1.00838319 |
| 71 | MP0005535_abnormal_body_temperature | 0.99771918 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97975527 |
| 73 | MP0005248_abnormal_Harderian_gland | 0.97264980 |
| 74 | MP0000767_abnormal_smooth_muscle | 0.97001755 |
| 75 | MP0000604_amyloidosis | 0.96758705 |
| 76 | MP0000049_abnormal_middle_ear | 0.93900893 |
| 77 | MP0009053_abnormal_anal_canal | 0.93338776 |
| 78 | MP0003385_abnormal_body_wall | 0.93204483 |
| 79 | MP0002938_white_spotting | 0.92698232 |
| 80 | MP0003566_abnormal_cell_adhesion | 0.92496958 |
| 81 | MP0009384_cardiac_valve_regurgitation | 0.91262413 |
| 82 | MP0003868_abnormal_feces_composition | 0.87959246 |
| 83 | MP0002896_abnormal_bone_mineralization | 0.87112690 |
| 84 | MP0000163_abnormal_cartilage_morphology | 0.85821369 |
| 85 | MP0005448_abnormal_energy_balance | 0.85609262 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.85283709 |
| 87 | MP0002697_abnormal_eye_size | 0.85261517 |
| 88 | MP0003453_abnormal_keratinocyte_physiol | 0.84859540 |
| 89 | MP0002233_abnormal_nose_morphology | 0.84123539 |
| 90 | MP0002970_abnormal_white_adipose | 0.84066317 |
| 91 | MP0003011_delayed_dark_adaptation | 0.82784791 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.82168573 |
| 93 | MP0009115_abnormal_fat_cell | 0.81942119 |
| 94 | MP0004134_abnormal_chest_morphology | 0.81123430 |
| 95 | MP0001944_abnormal_pancreas_morphology | 0.80938522 |
| 96 | MP0001879_abnormal_lymphatic_vessel | 0.80194343 |
| 97 | MP0006138_congestive_heart_failure | 0.79986086 |
| 98 | MP0009672_abnormal_birth_weight | 0.78990878 |
| 99 | MP0005330_cardiomyopathy | 0.78547512 |
| 100 | MP0003300_gastrointestinal_ulcer | 0.76262278 |
| 101 | MP0005408_hypopigmentation | 0.75170812 |
| 102 | MP0003937_abnormal_limbs/digits/tail_de | 0.75098305 |
| 103 | MP0005197_abnormal_uvea_morphology | 0.74456716 |
| 104 | MP0003890_abnormal_embryonic-extraembry | 0.73167168 |
| 105 | MP0004264_abnormal_extraembryonic_tissu | 0.72215151 |
| 106 | MP0005379_endocrine/exocrine_gland_phen | 0.72187459 |
| 107 | MP0000432_abnormal_head_morphology | 0.71624793 |
| 108 | MP0003186_abnormal_redox_activity | 0.71614213 |
| 109 | MP0003959_abnormal_lean_body | 0.71252817 |
| 110 | MP0002116_abnormal_craniofacial_bone | 0.70718390 |
| 111 | MP0000747_muscle_weakness | 0.70480184 |
| 112 | MP0010352_gastrointestinal_tract_polyps | 0.70420864 |
| 113 | MP0010771_integument_phenotype | 0.70290322 |
| 114 | MP0004087_abnormal_muscle_fiber | 0.68374035 |
| 115 | MP0002269_muscular_atrophy | 0.66991243 |
| 116 | MP0005451_abnormal_body_composition | 0.66612373 |
| 117 | MP0010386_abnormal_urinary_bladder | 0.65880594 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.65842136 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.65659681 |
| 120 | MP0002177_abnormal_outer_ear | 0.65180112 |
| 121 | MP0003091_abnormal_cell_migration | 0.65045974 |
| 122 | MP0003935_abnormal_craniofacial_develop | 0.64966862 |
| 123 | MP0001756_abnormal_urination | 0.64297391 |
| 124 | MP0003045_fibrosis | 0.63544600 |
| 125 | MP0002295_abnormal_pulmonary_circulatio | 0.63349748 |
| 126 | MP0002115_abnormal_skeleton_extremities | 0.63239504 |
| 127 | MP0002332_abnormal_exercise_endurance | 0.63152525 |
| 128 | MP0004885_abnormal_endolymph | 0.63110525 |
| 129 | MP0000751_myopathy | 0.62152662 |
| 130 | MP0001243_abnormal_dermal_layer | 0.62011063 |
| 131 | MP0001286_abnormal_eye_development | 0.61653900 |
| 132 | MP0004859_abnormal_synaptic_plasticity | 0.60918920 |
| 133 | MP0000579_abnormal_nail_morphology | 0.60169009 |
| 134 | MP0003690_abnormal_glial_cell | 0.59840026 |
| 135 | MP0003122_maternal_imprinting | 0.59725066 |
| 136 | MP0005076_abnormal_cell_differentiation | 0.59386159 |
| 137 | MP0002090_abnormal_vision | 0.59036096 |
| 138 | MP0001177_atelectasis | 0.58393721 |
| 139 | MP0000762_abnormal_tongue_morphology | 0.57917735 |
| 140 | MP0003075_altered_response_to | 0.56088918 |
| 141 | MP0000598_abnormal_liver_morphology | 0.55034753 |
| 142 | MP0002234_abnormal_pharynx_morphology | 0.53400165 |
| 143 | MP0001216_abnormal_epidermal_layer | 0.53065090 |
| 144 | MP0003953_abnormal_hormone_level | 0.52819116 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.51191491 |
| 146 | MP0000639_abnormal_adrenal_gland | 0.51009128 |
| 147 | MP0002876_abnormal_thyroid_physiology | 0.50533063 |
| 148 | MP0001348_abnormal_lacrimal_gland | 0.50125885 |
| 149 | MP0001881_abnormal_mammary_gland | 0.49518458 |
| 150 | MP0001765_abnormal_ion_homeostasis | 0.49483929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.84791168 |
| 2 | Xanthomatosis (HP:0000991) | 4.59792311 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.29311526 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.19720146 |
| 5 | Broad metatarsal (HP:0001783) | 3.71583966 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 3.63902423 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.62701741 |
| 8 | Vascular tortuosity (HP:0004948) | 3.56638352 |
| 9 | Abnormality of the Achilles tendon (HP:0005109) | 3.46150489 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.45287689 |
| 11 | Ketosis (HP:0001946) | 3.39609544 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.35527370 |
| 13 | Ankle contracture (HP:0006466) | 3.33994729 |
| 14 | Arterial tortuosity (HP:0005116) | 3.28238598 |
| 15 | Soft skin (HP:0000977) | 3.27639064 |
| 16 | Ketoacidosis (HP:0001993) | 3.24411819 |
| 17 | Achilles tendon contracture (HP:0001771) | 3.20753139 |
| 18 | Epidermoid cyst (HP:0200040) | 3.19286593 |
| 19 | Aortic dissection (HP:0002647) | 3.17967310 |
| 20 | Abnormality of dentin (HP:0010299) | 3.17300489 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.15123620 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.13011645 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.13011645 |
| 24 | Hypoalphalipoproteinemia (HP:0003233) | 3.12395566 |
| 25 | Turricephaly (HP:0000262) | 3.10052855 |
| 26 | Hyperglycinuria (HP:0003108) | 3.08095216 |
| 27 | Hyperglycinemia (HP:0002154) | 3.03754562 |
| 28 | Skin nodule (HP:0200036) | 3.00059997 |
| 29 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.91650679 |
| 30 | Complement deficiency (HP:0004431) | 2.91545928 |
| 31 | Cardiovascular calcification (HP:0011915) | 2.91042534 |
| 32 | Aortic aneurysm (HP:0004942) | 2.89478105 |
| 33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.89379146 |
| 34 | Premature rupture of membranes (HP:0001788) | 2.86990653 |
| 35 | Hyperammonemia (HP:0001987) | 2.83238924 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.74676191 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.74465630 |
| 38 | Abnormality of the intrinsic pathway (HP:0010989) | 2.73724464 |
| 39 | Neonatal short-limb short stature (HP:0008921) | 2.68834171 |
| 40 | Follicular hyperkeratosis (HP:0007502) | 2.67330798 |
| 41 | Abnormal gallbladder physiology (HP:0012438) | 2.66593074 |
| 42 | Cholecystitis (HP:0001082) | 2.66593074 |
| 43 | Fragile skin (HP:0001030) | 2.63953346 |
| 44 | Wormian bones (HP:0002645) | 2.63088606 |
| 45 | Atrophic scars (HP:0001075) | 2.62901023 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.59030925 |
| 47 | Bladder diverticulum (HP:0000015) | 2.58482111 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.54520977 |
| 49 | Acanthosis nigricans (HP:0000956) | 2.53354185 |
| 50 | Abnormality of the lower motor neuron (HP:0002366) | 2.48841552 |
| 51 | Abnormal cartilage morphology (HP:0002763) | 2.45840085 |
| 52 | Symptomatic seizures (HP:0011145) | 2.45309520 |
| 53 | Vascular calcification (HP:0004934) | 2.43062640 |
| 54 | Prolonged partial thromboplastin time (HP:0003645) | 2.42111857 |
| 55 | Spinal rigidity (HP:0003306) | 2.41796691 |
| 56 | Hyperextensible skin (HP:0000974) | 2.39938324 |
| 57 | Back pain (HP:0003418) | 2.38444489 |
| 58 | Right ventricular cardiomyopathy (HP:0011663) | 2.37787693 |
| 59 | Vertebral compression fractures (HP:0002953) | 2.36802683 |
| 60 | Abnormality of complement system (HP:0005339) | 2.30476853 |
| 61 | Abnormal gallbladder morphology (HP:0012437) | 2.29794465 |
| 62 | Hyperglycemia (HP:0003074) | 2.29053183 |
| 63 | Cholelithiasis (HP:0001081) | 2.28576501 |
| 64 | Hypercholesterolemia (HP:0003124) | 2.26272721 |
| 65 | Cerebral aneurysm (HP:0004944) | 2.25599091 |
| 66 | Genu recurvatum (HP:0002816) | 2.25517741 |
| 67 | Hyporeflexia of lower limbs (HP:0002600) | 2.24862471 |
| 68 | Neurofibrillary tangles (HP:0002185) | 2.23934037 |
| 69 | Hyperphosphatemia (HP:0002905) | 2.21278254 |
| 70 | Cervical subluxation (HP:0003308) | 2.16449334 |
| 71 | Myocardial infarction (HP:0001658) | 2.15975527 |
| 72 | Type 1 muscle fiber predominance (HP:0003803) | 2.15783221 |
| 73 | Hypoglycemic seizures (HP:0002173) | 2.15410613 |
| 74 | Peritonitis (HP:0002586) | 2.13581098 |
| 75 | Blue sclerae (HP:0000592) | 2.11929530 |
| 76 | Overgrowth (HP:0001548) | 2.11884576 |
| 77 | Bronchomalacia (HP:0002780) | 2.11257345 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 2.08224430 |
| 79 | Hydroxyprolinuria (HP:0003080) | 2.08224430 |
| 80 | Congenital glaucoma (HP:0001087) | 2.05582988 |
| 81 | Global brain atrophy (HP:0002283) | 2.02584515 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02246307 |
| 83 | Coronal craniosynostosis (HP:0004440) | 2.01999778 |
| 84 | Increased connective tissue (HP:0009025) | 1.98969243 |
| 85 | Fat malabsorption (HP:0002630) | 1.98635888 |
| 86 | Malnutrition (HP:0004395) | 1.97560577 |
| 87 | Oligomenorrhea (HP:0000876) | 1.96648827 |
| 88 | Abnormality of the acetabulum (HP:0003170) | 1.95605763 |
| 89 | Myoglobinuria (HP:0002913) | 1.95573466 |
| 90 | Gout (HP:0001997) | 1.93850474 |
| 91 | Pseudobulbar signs (HP:0002200) | 1.93518197 |
| 92 | Mitral stenosis (HP:0001718) | 1.91296037 |
| 93 | Lymphangioma (HP:0100764) | 1.90962747 |
| 94 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88997506 |
| 95 | Delayed CNS myelination (HP:0002188) | 1.88091238 |
| 96 | Amyloidosis (HP:0011034) | 1.86943540 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 1.86776327 |
| 98 | Unilateral renal agenesis (HP:0000122) | 1.86495428 |
| 99 | Abnormality of purine metabolism (HP:0004352) | 1.86493954 |
| 100 | Late onset (HP:0003584) | 1.86079561 |
| 101 | Shallow orbits (HP:0000586) | 1.85270707 |
| 102 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.82022733 |
| 103 | Upper limb amyotrophy (HP:0009129) | 1.81702711 |
| 104 | Distal upper limb amyotrophy (HP:0007149) | 1.81702711 |
| 105 | Mitral valve prolapse (HP:0001634) | 1.81149852 |
| 106 | Joint laxity (HP:0001388) | 1.80138404 |
| 107 | Hepatocellular carcinoma (HP:0001402) | 1.79925680 |
| 108 | Conjunctival hamartoma (HP:0100780) | 1.79434714 |
| 109 | Multiple enchondromatosis (HP:0005701) | 1.79225182 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.78201802 |
| 111 | Wide anterior fontanel (HP:0000260) | 1.77853340 |
| 112 | Neonatal onset (HP:0003623) | 1.76936099 |
| 113 | Abnormal delivery (HP:0001787) | 1.76932555 |
| 114 | Ectopia lentis (HP:0001083) | 1.76280516 |
| 115 | Insulin resistance (HP:0000855) | 1.74883513 |
| 116 | Osteoarthritis (HP:0002758) | 1.74779394 |
| 117 | Hamartoma of the eye (HP:0010568) | 1.74535111 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.73693758 |
| 119 | Buphthalmos (HP:0000557) | 1.73152393 |
| 120 | Irritability (HP:0000737) | 1.72351344 |
| 121 | Aneurysm (HP:0002617) | 1.71925799 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 1.71291276 |
| 123 | Abnormal hemoglobin (HP:0011902) | 1.70539389 |
| 124 | Abnormality of molar morphology (HP:0011070) | 1.70064186 |
| 125 | Abnormality of molar (HP:0011077) | 1.70064186 |
| 126 | Status epilepticus (HP:0002133) | 1.69056492 |
| 127 | Hypoventilation (HP:0002791) | 1.67142579 |
| 128 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.66773273 |
| 129 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.66773273 |
| 130 | Aortic regurgitation (HP:0001659) | 1.66251952 |
| 131 | Difficulty running (HP:0009046) | 1.63522249 |
| 132 | Ankyloglossia (HP:0010296) | 1.63295292 |
| 133 | Hypercortisolism (HP:0001578) | 1.63028063 |
| 134 | Spastic diplegia (HP:0001264) | 1.62595167 |
| 135 | Resting tremor (HP:0002322) | 1.62130900 |
| 136 | Proximal tubulopathy (HP:0000114) | 1.62110581 |
| 137 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.61035094 |
| 138 | Hyperbilirubinemia (HP:0002904) | 1.59894279 |
| 139 | Hyperthyroidism (HP:0000836) | 1.59518262 |
| 140 | Biconcave vertebral bodies (HP:0004586) | 1.59276127 |
| 141 | Hyperparathyroidism (HP:0000843) | 1.58638523 |
| 142 | Bowel diverticulosis (HP:0005222) | 1.57801145 |
| 143 | Testicular atrophy (HP:0000029) | 1.57588246 |
| 144 | Rickets (HP:0002748) | 1.54872928 |
| 145 | Metabolic acidosis (HP:0001942) | 1.54622699 |
| 146 | Nonimmune hydrops fetalis (HP:0001790) | 1.54600776 |
| 147 | Venous abnormality (HP:0002624) | 1.53155377 |
| 148 | Dilatation of the ascending aorta (HP:0005111) | 1.51149787 |
| 149 | Slender build (HP:0001533) | 1.50049804 |
| 150 | Focal segmental glomerulosclerosis (HP:0000097) | 1.49519994 |
| 151 | Enlarged penis (HP:0000040) | 1.48920235 |
| 152 | Elbow flexion contracture (HP:0002987) | 1.47105722 |
| 153 | Ovoid vertebral bodies (HP:0003300) | 1.46652449 |
| 154 | Coxa vara (HP:0002812) | 1.46581236 |
| 155 | Mitral regurgitation (HP:0001653) | 1.45387954 |
| 156 | Pterygium (HP:0001059) | 1.44814368 |
| 157 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.44421178 |
| 158 | Osteolytic defects of the hand bones (HP:0009699) | 1.44421178 |
| 159 | Partial duplication of the phalanx of hand (HP:0009999) | 1.43752159 |
| 160 | Rhizomelia (HP:0008905) | 1.43213188 |
| 161 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.42693173 |
| 162 | Breech presentation (HP:0001623) | 1.42509384 |
| 163 | Knee flexion contracture (HP:0006380) | 1.42459437 |
| 164 | Limited hip movement (HP:0008800) | 1.40180311 |
| 165 | Abnormality of permanent molar morphology (HP:0011071) | 1.39990440 |
| 166 | Abnormality of the dental root (HP:0006486) | 1.39990440 |
| 167 | Taurodontia (HP:0000679) | 1.39990440 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.49031880 |
| 2 | ERN1 | 3.06206929 |
| 3 | PKN2 | 2.94399388 |
| 4 | MYLK | 2.92031715 |
| 5 | SIK1 | 2.74892081 |
| 6 | BCKDK | 2.60382598 |
| 7 | PDGFRA | 2.25618852 |
| 8 | LATS2 | 2.16106595 |
| 9 | TNIK | 2.10463769 |
| 10 | MAP3K2 | 2.10165413 |
| 11 | PNCK | 2.06219893 |
| 12 | STK24 | 2.01364157 |
| 13 | NTRK1 | 1.97932135 |
| 14 | MAP2K4 | 1.82547201 |
| 15 | RIPK1 | 1.81178904 |
| 16 | NEK9 | 1.76652604 |
| 17 | PRKD3 | 1.72900294 |
| 18 | FER | 1.70811374 |
| 19 | LATS1 | 1.68195358 |
| 20 | KSR2 | 1.67281573 |
| 21 | TESK1 | 1.65839105 |
| 22 | TRPM7 | 1.65717771 |
| 23 | AKT3 | 1.59312863 |
| 24 | FRK | 1.58802980 |
| 25 | MAP3K9 | 1.58714737 |
| 26 | DDR2 | 1.54814612 |
| 27 | TYRO3 | 1.49060624 |
| 28 | GRK5 | 1.43620377 |
| 29 | MST1R | 1.43599902 |
| 30 | PTK6 | 1.42541168 |
| 31 | BMX | 1.39654523 |
| 32 | RET | 1.39038261 |
| 33 | STK38L | 1.32709595 |
| 34 | MET | 1.29786097 |
| 35 | FGFR2 | 1.28791643 |
| 36 | EPHA2 | 1.27272243 |
| 37 | BRSK2 | 1.26444127 |
| 38 | WNK4 | 1.20711798 |
| 39 | FGFR4 | 1.20485850 |
| 40 | PRKG2 | 1.19972340 |
| 41 | WNK1 | 1.19848983 |
| 42 | CASK | 1.19263281 |
| 43 | NTRK3 | 1.16374831 |
| 44 | PAK3 | 1.13000742 |
| 45 | PTK2 | 1.09966154 |
| 46 | LIMK1 | 1.09673379 |
| 47 | MST4 | 1.08725678 |
| 48 | ICK | 1.08163211 |
| 49 | CDK12 | 1.06275702 |
| 50 | PDK3 | 1.06257885 |
| 51 | PDK4 | 1.06257885 |
| 52 | CAMK1D | 1.04093735 |
| 53 | LMTK2 | 0.98569107 |
| 54 | CAMK1G | 0.98567255 |
| 55 | EPHA4 | 0.95727292 |
| 56 | MAP3K1 | 0.95366410 |
| 57 | MAP3K10 | 0.93680086 |
| 58 | ALK | 0.93109466 |
| 59 | DAPK2 | 0.92020763 |
| 60 | TAF1 | 0.90840340 |
| 61 | MAP2K1 | 0.90828211 |
| 62 | PAK6 | 0.89889030 |
| 63 | MAP3K4 | 0.89133988 |
| 64 | MAP3K7 | 0.88744073 |
| 65 | STK39 | 0.88605192 |
| 66 | EIF2AK1 | 0.87324501 |
| 67 | STK38 | 0.86888558 |
| 68 | ILK | 0.84567508 |
| 69 | MAP3K3 | 0.84371053 |
| 70 | EPHB2 | 0.84259245 |
| 71 | MAP3K12 | 0.84230207 |
| 72 | TAOK1 | 0.83680508 |
| 73 | MINK1 | 0.83438574 |
| 74 | TGFBR2 | 0.83117715 |
| 75 | PASK | 0.82201927 |
| 76 | PRKCH | 0.81099163 |
| 77 | MTOR | 0.79522578 |
| 78 | PAK4 | 0.76966482 |
| 79 | INSRR | 0.75171540 |
| 80 | EEF2K | 0.74770608 |
| 81 | EPHB1 | 0.74103207 |
| 82 | PRKD1 | 0.73011283 |
| 83 | CAMKK1 | 0.71327899 |
| 84 | SCYL2 | 0.70280884 |
| 85 | GRK1 | 0.70157852 |
| 86 | PRKCE | 0.68266415 |
| 87 | FLT3 | 0.67752317 |
| 88 | FGFR1 | 0.67713567 |
| 89 | PDPK1 | 0.67240858 |
| 90 | PDGFRB | 0.67191792 |
| 91 | HIPK2 | 0.66428964 |
| 92 | TTK | 0.66255462 |
| 93 | CDK6 | 0.65728139 |
| 94 | DMPK | 0.65570131 |
| 95 | JAK2 | 0.65222983 |
| 96 | GSK3A | 0.64927255 |
| 97 | ABL2 | 0.63550812 |
| 98 | MAP3K11 | 0.63511424 |
| 99 | CAMK2D | 0.63414289 |
| 100 | TAOK3 | 0.62920030 |
| 101 | MOS | 0.62662121 |
| 102 | PAK2 | 0.62359147 |
| 103 | DYRK1B | 0.61538798 |
| 104 | PTK2B | 0.61425061 |
| 105 | TTN | 0.60577100 |
| 106 | STK11 | 0.60119634 |
| 107 | FGFR3 | 0.60033300 |
| 108 | ROCK2 | 0.59738647 |
| 109 | STK3 | 0.59498619 |
| 110 | PRKCG | 0.59148676 |
| 111 | PHKG1 | 0.58892343 |
| 112 | PHKG2 | 0.58892343 |
| 113 | NEK2 | 0.58026460 |
| 114 | ERBB4 | 0.57978463 |
| 115 | MKNK2 | 0.56958526 |
| 116 | NLK | 0.56911237 |
| 117 | LRRK2 | 0.56405255 |
| 118 | GRK6 | 0.55638483 |
| 119 | ROCK1 | 0.55169531 |
| 120 | MARK2 | 0.55095382 |
| 121 | STK16 | 0.54731942 |
| 122 | MAP3K6 | 0.54536302 |
| 123 | UHMK1 | 0.54035904 |
| 124 | DAPK3 | 0.51324887 |
| 125 | PRKAA2 | 0.50362701 |
| 126 | PLK3 | 0.50361603 |
| 127 | STK4 | 0.49358693 |
| 128 | PLK2 | 0.48203058 |
| 129 | PINK1 | 0.48177516 |
| 130 | PRKAA1 | 0.48104412 |
| 131 | PRKACG | 0.47893981 |
| 132 | MAPK7 | 0.47143771 |
| 133 | CDK5 | 0.46498679 |
| 134 | PIK3CA | 0.45821514 |
| 135 | PRKD2 | 0.45368268 |
| 136 | WEE1 | 0.45263019 |
| 137 | CDC42BPA | 0.45065183 |
| 138 | PDK1 | 0.44509431 |
| 139 | MAP2K2 | 0.43774575 |
| 140 | PDK2 | 0.43758589 |
| 141 | TIE1 | 0.43648498 |
| 142 | ADRBK1 | 0.42268346 |
| 143 | PIK3CG | 0.41009798 |
| 144 | CAMK1 | 0.40733629 |
| 145 | BRSK1 | 0.40409757 |
| 146 | PRKCZ | 0.40232914 |
| 147 | CSNK1E | 0.37830438 |
| 148 | CDK3 | 0.37158824 |
| 149 | WNK3 | 0.36617154 |
| 150 | MAPKAPK3 | 0.36284854 |
| 151 | BRAF | 0.36115451 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.56603017 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.83220689 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61030677 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.46782920 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41848863 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.35796430 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20752784 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.14513130 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.14029233 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11392908 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.08351355 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08011521 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05823899 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.97786792 |
| 15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.91936432 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65614276 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.60302877 |
| 18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58255454 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57685133 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55379194 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55342174 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.53690547 |
| 23 | Protein export_Homo sapiens_hsa03060 | 1.52269201 |
| 24 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.49448649 |
| 25 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49149280 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48104188 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.43096679 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.42077749 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.39084229 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37699861 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.36225577 |
| 32 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35854517 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35808042 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.33420480 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.26575540 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.23851640 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23077686 |
| 38 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.22212099 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 1.22141611 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18553074 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.13596592 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12073831 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10054532 |
| 44 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.08212628 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03081335 |
| 46 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.01037917 |
| 47 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97874492 |
| 48 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.94438213 |
| 49 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.93150508 |
| 50 | Retinol metabolism_Homo sapiens_hsa00830 | 0.92164259 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88419204 |
| 52 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88127120 |
| 53 | Adherens junction_Homo sapiens_hsa04520 | 0.88092444 |
| 54 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.87717504 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87122192 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.86135398 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85660668 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84744606 |
| 59 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.82872625 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.79968460 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.78714240 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77244763 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.77237662 |
| 64 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.77199297 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.75231982 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.74760251 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.74452693 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74290180 |
| 69 | Insulin resistance_Homo sapiens_hsa04931 | 0.73888446 |
| 70 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73286940 |
| 71 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.73114903 |
| 72 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.69939519 |
| 73 | Tight junction_Homo sapiens_hsa04530 | 0.69046243 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67528123 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66368287 |
| 76 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.65648206 |
| 77 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65041767 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.61346994 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60528435 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.60402337 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.59256030 |
| 82 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59194198 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58950338 |
| 84 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58567491 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.58476341 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57178342 |
| 87 | Melanoma_Homo sapiens_hsa05218 | 0.55213300 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.55112090 |
| 89 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53081101 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53004010 |
| 91 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52209612 |
| 92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50691486 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.50181207 |
| 94 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.49249771 |
| 95 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48598476 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48011703 |
| 97 | Prion diseases_Homo sapiens_hsa05020 | 0.47276762 |
| 98 | Ribosome_Homo sapiens_hsa03010 | 0.46905641 |
| 99 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.46624357 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46544645 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46334985 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46284120 |
| 103 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46159453 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.44204769 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | 0.43475831 |
| 106 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43202311 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40607336 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40388493 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39852292 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39531945 |
| 111 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37648972 |
| 112 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.37573583 |
| 113 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37221379 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.37021086 |
| 115 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36920223 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.36890824 |
| 117 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35993056 |
| 118 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34971182 |
| 119 | GABAergic synapse_Homo sapiens_hsa04727 | 0.33859399 |
| 120 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32084695 |
| 121 | Amoebiasis_Homo sapiens_hsa05146 | 0.31477075 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31098232 |
| 123 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.30927800 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30462907 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.30402110 |
| 126 | Focal adhesion_Homo sapiens_hsa04510 | 0.28685682 |
| 127 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.28516427 |
| 128 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.28281570 |

